• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型犬尿氨酸类似物:与犬尿氨酸的比较。一项体外电生理学研究。

A novel kynurenic acid analogue: a comparison with kynurenic acid. An in vitro electrophysiological study.

机构信息

Department of Physiology, Anatomy and Neuroscience, University of Szeged, Közép fasor 52, 6726 Szeged, Hungary.

出版信息

J Neural Transm (Vienna). 2010 Feb;117(2):183-8. doi: 10.1007/s00702-009-0346-2. Epub 2009 Dec 2.

DOI:10.1007/s00702-009-0346-2
PMID:19953278
Abstract

Kynurenic acid is an endogenous product of the tryptophan metabolism, and as a broad-spectrum antagonist of excitatory amino acid receptors may serve as a protective agent in neurological disorders. The use of kynurenic acid as a neuroprotective agent is rather limited, however, because it has only restricted ability to cross the blood-brain barrier. Accordingly, new kynurenic acid analogues which can readily cross the blood-brain barrier and exert their complex anti-excitotoxic activity are greatly needed. Such a novel analogue, 2-(2-N,N-dimethylaminoethylamine-1-carbonyl)-1H-quinolin-4-one hydrochloride, has been developed and tested. In an in vitro electrophysiological study, in which its properties were compared with those of kynurenic acid, the new analogue behaved quite similarly to kynurenic acid: in the micromolar range, its administration led to a decrease in the amplitudes of the field excitatory postsynaptic potentials in the CA1 region of the hippocampus, while in nanomolar concentrations it did not give rise to inhibition, but, in fact, facilitated the field excitatory postsynaptic potentials. Moreover, the new analogue demonstrated similar protective action against PTZ-induced facilitation to that observed after kynurenic acid administration. The findings strongly suggest that the neuroactive effects of the new analogue are comparable with those of kynurenic acid, but, in contrast with kynurenic acid, it readily crosses the blood-brain barrier. The new analogue may therefore be considered a promising candidate for clinical studies.

摘要

犬尿酸是色氨酸代谢的内源性产物,作为一种广泛的兴奋性氨基酸受体拮抗剂,可能在神经疾病中作为一种保护剂。然而,犬尿酸作为一种神经保护剂的用途相当有限,因为它只有有限的能力穿过血脑屏障。因此,需要开发和测试能够轻易穿过血脑屏障并发挥其复杂抗兴奋毒性作用的新犬尿酸类似物。已经开发并测试了一种新型类似物,2-(2-N,N-二甲基氨基乙基胺-1-羰基)-1H-喹啉-4-酮盐酸盐。在一项体外电生理学研究中,将其特性与犬尿酸进行了比较,新型类似物的行为与犬尿酸非常相似:在微摩尔范围内,其给药导致海马 CA1 区场兴奋性突触后电位的幅度降低,而在纳摩尔浓度下,它不会引起抑制,而是实际上促进了场兴奋性突触后电位。此外,新型类似物对 PTZ 诱导的易化表现出与犬尿酸给药后观察到的类似的保护作用。这些发现强烈表明,新型类似物的神经活性作用与犬尿酸相当,但与犬尿酸不同的是,它很容易穿过血脑屏障。因此,该新型类似物可被认为是临床研究的有前途的候选物。

相似文献

1
A novel kynurenic acid analogue: a comparison with kynurenic acid. An in vitro electrophysiological study.一种新型犬尿氨酸类似物:与犬尿氨酸的比较。一项体外电生理学研究。
J Neural Transm (Vienna). 2010 Feb;117(2):183-8. doi: 10.1007/s00702-009-0346-2. Epub 2009 Dec 2.
2
The Janus-face kynurenic acid.两面神面孔的犬尿喹啉酸。
J Neural Transm (Vienna). 2008 Aug;115(8):1087-91. doi: 10.1007/s00702-008-0052-5. Epub 2008 Apr 30.
3
Synthesis and biological effects of some kynurenic acid analogs.一些犬尿氨酸类似物的合成及生物效应。
Bioorg Med Chem. 2011 Dec 15;19(24):7590-6. doi: 10.1016/j.bmc.2011.10.029. Epub 2011 Oct 18.
4
Effects of central and peripheral administration of kynurenic acid on hippocampal evoked responses in vivo and in vitro.犬尿喹啉酸中枢和外周给药对体内及体外海马诱发反应的影响。
Neuroscience. 1998 Oct;86(3):751-64. doi: 10.1016/s0306-4522(98)00073-6.
5
Systemically administered glucosamine-kynurenic acid, but not pure kynurenic acid, is effective in decreasing the evoked activity in area CA1 of the rat hippocampus.全身给药的葡萄糖胺-犬尿氨酸,而非单纯的犬尿氨酸,可有效降低大鼠海马体CA1区的诱发活动。
Eur J Pharmacol. 2005 Apr 18;513(1-2):75-80. doi: 10.1016/j.ejphar.2005.02.043. Epub 2005 Apr 7.
6
Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats.犬尿喹啉酸可阻断幼鼠海马中间神经元的烟碱型突触传递。
Eur J Neurosci. 2007 May;25(9):2656-65. doi: 10.1111/j.1460-9568.2007.05540.x. Epub 2007 Apr 25.
7
Structural Evaluation and Electrophysiological Effects of Some Kynurenic Acid Analogs.一些犬尿氨酸类似物的结构评估和电生理效应。
Molecules. 2019 Sep 26;24(19):3502. doi: 10.3390/molecules24193502.
8
Paradox effects of kynurenines on LTP induction in the Wistar rat. An in vivo study.犬尿氨酸对 Wistar 大鼠 LTP 诱导的矛盾作用。一项体内研究。
Neurosci Lett. 2013 Oct 11;553:138-41. doi: 10.1016/j.neulet.2013.08.028. Epub 2013 Aug 23.
9
Modifications on the carboxylic function of kynurenic acid.对犬尿酸羧酸功能的修饰。
J Neural Transm (Vienna). 2012 Feb;119(2):109-14. doi: 10.1007/s00702-011-0721-7. Epub 2011 Oct 14.
10
Comparing long-term depression with pharmacologically induced synaptic attenuations in young rat hippocampi.比较幼鼠海马体中长时程抑制与药理学诱导的突触减弱。
Synapse. 1997 Aug;26(4):329-40. doi: 10.1002/(SICI)1098-2396(199708)26:4<329::AID-SYN1>3.0.CO;2-8.

引用本文的文献

1
Alkoxyalkylation of Electron-Rich Aromatic Compounds.电子富芳族化合物的烷氧基烷基化反应。
Int J Mol Sci. 2024 Jun 26;25(13):6966. doi: 10.3390/ijms25136966.
2
C-3 alkoxymethylation of 4-oxo-1,4-dihydroquinoline 2-carboxylic acid esters organic additives.4-氧代-1,4-二氢喹啉-2-羧酸酯的C-3烷氧基甲基化 有机添加剂
Heliyon. 2024 May 31;10(11):e32188. doi: 10.1016/j.heliyon.2024.e32188. eCollection 2024 Jun 15.
3
Role of Kynurenine Pathway in Oxidative Stress during Neurodegenerative Disorders.犬尿氨酸途径在神经退行性疾病氧化应激中的作用。

本文引用的文献

1
The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: comparative studies of the effects of SZR-72 and kynurenic acid.犬尿喹啉酸类似物SZR-72可预防硝酸甘油诱导的大鼠尾侧三叉神经核中c-fos免疫反应性增加:SZR-72与犬尿烯酸作用的比较研究
Neurosci Res. 2008 Aug;61(4):429-32. doi: 10.1016/j.neures.2008.04.009. Epub 2008 May 2.
2
The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: an in vitro study.一项体外研究表明:L-犬尿氨酸向犬尿酸的转化可抑制戊四氮诱导的海马体活性。
Brain Res Bull. 2008 Jul 30;76(5):474-9. doi: 10.1016/j.brainresbull.2007.12.001. Epub 2007 Dec 28.
3
Cells. 2021 Jun 26;10(7):1603. doi: 10.3390/cells10071603.
4
Kynurenic Acid Analog Attenuates the Production of Tumor Necrosis Factor-α, Calgranulins (S100A 8/9 and S100A 12), and the Secretion of HNP1-3 and Stimulates the Production of Tumor Necrosis Factor-Stimulated Gene-6 in Whole Blood Cultures of Patients With Rheumatoid Arthritis.犬尿酸类似物可减弱肿瘤坏死因子-α、钙粒蛋白(S100A8/9 和 S100A12)的产生以及 HNP1-3 的分泌,并刺激类风湿关节炎患者全血培养物中肿瘤坏死因子刺激基因-6 的产生。
Front Immunol. 2021 Apr 9;12:632513. doi: 10.3389/fimmu.2021.632513. eCollection 2021.
5
Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism.犬尿氨酸在痴呆中是帮凶还是主谋?犬尿氨酸代谢的维持。
Molecules. 2020 Jan 28;25(3):564. doi: 10.3390/molecules25030564.
6
Structural Evaluation and Electrophysiological Effects of Some Kynurenic Acid Analogs.一些犬尿氨酸类似物的结构评估和电生理效应。
Molecules. 2019 Sep 26;24(19):3502. doi: 10.3390/molecules24193502.
7
A comparative assessment of two kynurenic acid analogs in the formalin model of trigeminal activation: a behavioral, immunohistochemical and pharmacokinetic study.在三叉神经激活的福尔马林模型中对两种犬尿喹啉酸类似物的比较评估:一项行为学、免疫组织化学和药代动力学研究。
J Neural Transm (Vienna). 2017 Jan;124(1):99-112. doi: 10.1007/s00702-016-1615-5. Epub 2016 Sep 14.
8
KYNA analogue SZR72 modifies CFA-induced dural inflammation- regarding expression of pERK1/2 and IL-1β in the rat trigeminal ganglion.犬尿喹啉酸类似物SZR72改善弗氏完全佐剂诱导的硬脑膜炎症——关于大鼠三叉神经节中pERK1/2和白细胞介素-1β的表达
J Headache Pain. 2016 Dec;17(1):64. doi: 10.1186/s10194-016-0654-5. Epub 2016 Jul 5.
9
Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.美金刚与犬尿喹啉酸:当前神经药理学研究进展
Curr Neuropharmacol. 2016;14(2):200-9. doi: 10.2174/1570159x14666151113123221.
10
Changing the face of kynurenines and neurotoxicity: therapeutic considerations.犬尿氨酸与神经毒性的面貌改变:治疗方面的考量
Int J Mol Sci. 2015 Apr 29;16(5):9772-93. doi: 10.3390/ijms16059772.
The Janus-face kynurenic acid.两面神面孔的犬尿喹啉酸。
J Neural Transm (Vienna). 2008 Aug;115(8):1087-91. doi: 10.1007/s00702-008-0052-5. Epub 2008 Apr 30.
4
Tryptophan, adenosine, neurodegeneration and neuroprotection.色氨酸、腺苷、神经退行性变与神经保护
Metab Brain Dis. 2007 Dec;22(3-4):337-52. doi: 10.1007/s11011-007-9064-3.
5
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.线粒体、代谢紊乱、氧化应激与犬尿氨酸系统,重点关注神经退行性疾病
J Neurol Sci. 2007 Jun 15;257(1-2):221-39. doi: 10.1016/j.jns.2007.01.033. Epub 2007 Apr 25.
6
Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists.基于谷氨酸的治疗方法:NMDA拮抗剂的临床试验
Curr Opin Pharmacol. 2006 Feb;6(1):53-60. doi: 10.1016/j.coph.2005.12.002. Epub 2005 Dec 15.
7
Role of kynurenines in the central and peripheral nervous systems.犬尿氨酸在中枢和外周神经系统中的作用。
Curr Neurovasc Res. 2005 Jul;2(3):249-60. doi: 10.2174/1567202054368326.
8
Comparative study on the effects of kynurenic acid and glucosamine-kynurenic acid.犬尿喹啉酸与氨基葡萄糖-犬尿喹啉酸作用效果的比较研究
Pharmacol Biochem Behav. 2004 Jan;77(1):95-102. doi: 10.1016/j.pbb.2003.10.001.
9
The pharmacological manipulation of glutamate receptors and neuroprotection.谷氨酸受体的药理调控与神经保护
Eur J Pharmacol. 2002 Jul 5;447(2-3):285-96. doi: 10.1016/s0014-2999(02)01851-4.
10
Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals.释放刺激型α7*烟碱型胆碱能受体定位于人和大鼠脑谷氨酸能轴突终末的直接证据。
J Neurochem. 2002 Mar;80(6):1071-8. doi: 10.1046/j.0022-3042.2002.00805.x.